Prima Mente ยท 2 weeks ago
GPU Accelerated Bioinformatics Engineer
Prima Mente is a frontier biology AI lab focused on generating data and building biological foundation models. They are seeking a GPU Accelerated Bioinformatics Engineer to architect and build scalable production pipelines for processing multi-omics data, optimizing performance and collaborating with AI and experimental teams.
Artificial Intelligence (AI)BiotechnologyNeuroscience
Responsibilities
Design and implement GPU-native bioinformatics pipelines using Flyte and/or Nextflow for multi-omics data processing at scale (1000+ samples)
Optimising cost and performance, leveraging GPU acceleration where it matters
Work with experimental and machine learning teams to confirm and refine computational findings, and to ensure processing aligns with model needs
Cloud infrastructure
Develop and manage specific external research collaborations with academic and industrial partners
Qualification
Required
Knowledge of GPU computing backbone, whether directly through GPU-accelerated bioinformatics (e.g., NVIDIA Parabricks, Clara, Rapids, etc.) or through the ability to identify GPU vs. CPU optimisation in other contexts
Operational software engineering skills: the ability to write high-quality code to be the backbone of our software stack
Strong working knowledge with cloud computing environments, including but not limited to AWS and GCP
First-hand deep experience with at least 2-3 large omics types (genomics, transcriptomics, chromatin accessibility, DNA methylation, histone modifications profiling, etc.)
Experience with end-to-end tools used to process multi-omic data from raw data all the way to analytical outputs. Good working knowledge of workflow managers (e.g., Flyte, Nextflow, Snakemake)
Familiar with data wrangling, analysis, and visualisation libraries using Python (preferable), R or Julia
Strong data engineering knowledge, including but not limited to experience with Spark, Hadoop, NoSQL
Company
Prima Mente
The AI Biology company.
Funding
Current Stage
Early StageTotal Funding
unknownKey Investors
Innovate UK
2024-03-20Grant
2023-01-01Seed
Company data provided by crunchbase